On June 15, 2005, Connecticut became the third state in the United States to provide public funding for research using adult and embryonic stem cells. The first year alone the state received 70 research proposals, most of them from researchers at the University of Connecticut and Yale University. Soon, some of the top researchers in the country left other states to take positions at Connecticut’s universities. Already home to major pharmaceutical companies, in 2011 the state launched the Bioscience Connecticut initiative, a plan to spend $850 million to build the state’s biomedical industry.

The governor’s office announced that the Jackson Laboratory for Genomic Medicine, a billion-dollar personalized medicine laboratory, would be located on the campus of the University of Connecticut, Farmington. StemCONN, a biennial international ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles